Drug profile · INN
esomeprazole magnesium
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium (ESOMEPRAZOLE MAGNESIUM) is a potassium-transporting atpase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — esomeprazole magnesium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
esomeprazole magnesium (ESOMEPRAZOLE MAGNESIUM) is a potassium-transporting atpase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium-transporting ATPase inhibitor
Primary target: Potassium-transporting ATPase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is esomeprazole magnesium?
esomeprazole magnesium (ESOMEPRAZOLE MAGNESIUM) is a potassium-transporting atpase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for esomeprazole magnesium?
ESOMEPRAZOLE MAGNESIUM is a marketed brand name for esomeprazole magnesium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of esomeprazole magnesium?
esomeprazole magnesium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.